About
the AD Study

Discover a clinical trial designed for individuals with Atopic Dermatitis. 


See If You Qualify

About the

AD Study


See If You Qualify

The COMPASS-2 AD study is studying an investigational injectable treatment that’s designed to help block certain signals in the body that may contribute to inflammation in people with atopic dermatitis.

There are three groups in this study, and if you are eligible to participate, you will be randomly assigned to one of these groups (like drawing numbers from a hat). Everyone who participates in the study will receive both the study drug and the placebo, but the doses and the order in which the drug or placebo is received will vary depending on the group you are assigned to. Neither you nor the study doctor will know which group you are assigned to.In this study, some participants will receive the investigational medication, and others will receive a placebo. A placebo looks just like the investigational medication but does not contain active medicine. This helps researchers compare results across groups.

You May Qualify If:

Man and Woman Icon

Are 18 to 75 years old

Calendar Icon Have had atopic dermatitis for at least 1 year Hand Irritation Icon

Have moderate to severe eczema — meaning it affects a noticeable area of your skin and causes ongoing symptoms that impact your daily life

Rx Icon Have tried prescription treatments that didn’t fully control your symptoms
See If You Qualify

What Does Participation Look Like?

Screening Period


Before you officially join the study, the team will spend some time getting to know your health history and how your eczema affects you. This helps everyone determine whether the study is a good fit. During this step, you may:

  • Talk through your medical history
  • Review the eczema treatments you currently use or have used in the past
  • Have your skin checked by the study team
  • Provide blood samples and other routine health tests
  • Have medical photos taken of your eczema lesions

This part of the process ensures the study can be carried out safely and that your health needs are fully considered.



Study Treatment Period

If you qualify and decide to move forward, you’ll take part in a series of study visits over the treatment period.

These visits give you a chance to connect with the study team regularly while they monitor your progress. At these visits, the team will:
Look closely at your skin to see how it’s responding
Ask about your symptoms, and how eczema is affecting your 
day-to-day life.

  • Check in on your overall health and well-being
  • Collect blood samples and perform other routine health tests
  • Take medical photos of your eczema lesions
  • Provide your study medication at no cost

If anything changes with your health, your study doctor may adjust or pause your study treatment to keep you safe. And always remember — you’re free to leave the study at any point, for any reason.

Follow-up Period

There will be two follow-up visits that will occur 30-45 days after your last dose of study medication. These check-ins allows the study team to see how you’re feeling and wrap up any remaining information needed from your participation.


See If You Qualify

Although this study may not improve your atopic dermatitis, your participation can help researchers better understand potential future treatment options. During the study, you’ll receive study-related care and study medication at no cost, and no insurance is required. Study sites may also offer compensation for time and travel.

As with any clinical trial, there may be some risks or side effects, and the study team will discuss these with you and monitor your health throughout the study. Taking part is completely voluntary, and you may leave the study at any time for any reason.

Screening Period


Before you officially join the study, the team will spend some time getting to know your health history and how your eczema affects you. This helps everyone determine whether the study is a good fit. During this step, you may:

This part of the process ensures the study can be carried out safely and that your health needs are fully considered.



Study Treatment Period

If you qualify and decide to move forward, you’ll take part in a series of study visits over the treatment period.

These visits give you a chance to connect with the study team regularly while they monitor your progress. At these visits, the team will:
Look closely at your skin to see how it’s responding
Ask about your symptoms, and how eczema is affecting your 
day-to-day life.

If anything changes with your health, your study doctor may adjust or pause your study treatment to keep you safe. And always remember — you’re free to leave the study at any point, for any reason.

Follow-up Period

There will be two follow-up visits that will occur 30-45 days after your last dose of study medication. These check-ins allows the study team to see how you’re feeling and wrap up any remaining information needed from your participation.


See If You Qualify

Although this study may not improve your atopic dermatitis, your participation can help researchers better understand potential future treatment options. During the study, you’ll receive study-related care and study medication at no cost, and no insurance is required. Study sites may also offer compensation for time and travel.

As with any clinical trial, there may be some risks or side effects, and the study team will discuss these with you and monitor your health throughout the study. Taking part is completely voluntary, and you may leave the study at any time for any reason.

Frequently Asked Questions

The study is sponsored by Bluefin Biomedicine, Inc.

Yes. All study medication is provided at no cost.

You’ll come in for regular study visits every two weeks where the team will check your skin, review your symptoms, ask how you’re feeling, and perform routine health tests.

Study sites may offer compensation for your time and travel.

Yes. Participation is completely voluntary, and you may leave the study at any time, for any reason.

The study doctor will review your medical needs. If you require other treatments, they will discuss the safest options with you and may adjust or stop study treatment if needed.

The study is sponsored by Bluefin Biomedicine, Inc.

Yes. All study medication is provided at no cost.

You’ll come in for regular study visits every two weeks where the team will check your skin, review your symptoms, ask how you’re feeling, and perform routine health tests.

Study sites may offer compensation for your time and travel.

Yes. Participation is completely voluntary, and you may leave the study at any time, for any reason.

The study doctor will review your medical needs. If you require other treatments, they will discuss the safest options with you and may adjust or stop study treatment if needed.


Find Out Whether This Study May Be Right for You